Congress Should Investigate Chinese IP Theft


By Frank Cullen


The House of Representatives recently formed a bipartisan committee to "investigate and submit policy recommendations" on ways to counter the threat posed by the Chinese Communist Party.

The move is welcome -- and long overdue. For decades, China has sought to weaken America, and enrich itself, by stealing cutting-edge technologies critical to our national security and economic well-being. Lawmakers would be wise to make this intellectual property theft the foundation of their investigation.

Consider China's ongoing campaign to appropriate U.S. companies' trade secrets -- the proprietary know-how that enables American firms to make everything from lifesaving medicines to next-generation alloys used in spacecraft. U.S. officials have estimated that China steals up to $600 billion of American intellectual property annually. This theft endangers the jobs of more than 45 million Americans who work in IP-intensive industries, which account for more than $6.5 trillion in economic output.

China sometimes tries to obtain this intellectual property through bullying -- essentially, requiring American companies that want to sell their goods to the Middle Kingdom's 1.4 billion consumers to partner with Chinese firms. For example, until last year, China mandated that foreign car companies partner with local auto manufacturers. China has required wind turbine and solar panel producers to make a certain percentage of their products in the country. Those local "partners" frequently use this access to sensitive information to learn American secrets and, eventually, reproduce the technology without any need for a U.S. partner.

Other times, Chinese nationals -- often working formally or informally for the Communist Party -- have outright pilfered trade secrets.

In November 2022, a U.S. court sentenced Chinese national Xu Yanjun to 20 years in prison for planning to steal trade secrets from multiple U.S. aeronautical companies. In 2018, Chinese company Sinovel Wind Group was convicted in a Wisconsin federal court for stealing technology from its American partner. A recent report by Boston company Cybereason revealed a Chinese campaign called "Operation CuckooBees" that stole the blueprints for hundreds of gigabytes of advanced technology.

Unfortunately, this espionage campaign has borne fruit. According to experts at Harvard's Kennedy School, China is on track to overtake the United States' technological dominance within the next decade.

And the Communist Party shows no signs of abandoning its goals. Just the opposite. President Xi has been elevating "technocrats" specializing in science and technology to positions of authority. In fact, nearly 40% of China's national policy-making body is now composed of technocrats determined to accelerate their nation's economic progress -- by hook or by crook.

For decades, China has sought to surpass the United States in high-tech fields by stealing Americans' best ideas. It's up to Congress to put a stop to this theft.

Frank Cullen is executive director of the Council for Innovation Promotion. This originally ran in The Hill.



More Resources


05/18/2024
Will the Biden-Trump Debates Matter?
It was the political equivalent of a new Taylor Swift album dropping in the night: At 8 a.m. on May 15, with no advance warning, President Biden challenged former president Donald Trump to a debate.

more info


05/18/2024
Panic Time? Biden Unlikely To Turn It Around
Joe Biden is probably going to lose this election. Many of us realize that already, I suspect, but grief is a process.

more info


05/18/2024
'Zuckbucks' Group Trains Election Offices
A 'Zuckbucks' group hosted a webinar advising election offices on how to take advantage of Biden's federal election interference.

more info


05/18/2024
A Battle Between Appearance and Reality
Trump is an expert at selling an appearance and Biden can't sell reality

more info


05/18/2024
Biden Is Losing, So He Has No Choice But To Debate
And so President Biden has agreed to debate Donald Trump. Not only is this decision perilous (though necessary), but the conditions agreed upon for the first debate are foolish and reflect an inexcusable misunderstanding of both candidates.

more info


05/18/2024
A Worm in the Apple of RFK Jr.'s New Camelot
With a week in which Robert F. Kennedy Jr. declared that a doctor had found a dead worm in his brain, which he then topped off with an abortion flip-flop, he is neither endearing himself with voters or his running mate.

more info


05/18/2024
Democrats' Problem With Working Class Voters
Friday on the RealClearPolitics radio show, Tom Bevan, Carl Cannon, and RCP White House correspondent Phil Wegmann discuss the Democratic Party's problem with working-class voters and the latest squabbling in Congress, plus controversies involving Kansas City Chiefs Kicker Harrison Butker and professional golfer Scottie Scheffler.

more info


05/18/2024
Speaker Johnson Is 'Tired of Making History'


more info


05/18/2024
Senate Democrats Have No Margin for Error in November


more info


05/18/2024
Inflation Isn't a Bug in the System, It's a Feature
May brings more bad economic news for hard-pressed American households.

more info


05/18/2024
Why an Uncertain World Needs To Take On More Risk


more info


05/18/2024
A Dangerous Road
Higher education institutions may come to regret considering Israel Divestment proposals for their endowments.

more info


05/18/2024
Why Many Jews Are Conflicted About Israel's War


more info


05/18/2024
Why I'm Skipping My 50th Reunion at Yale
I graduated from Yale University in 1974. As a first-generation American, the child of Holocaust survivors, and among the first women admitted to this incredible school, it is hard to adequately express how grateful I was for this opportunity. I have enjoyed returning to campus frequently over the years, including watching two of my own children graduate from Yale.

more info


05/18/2024
U.S. Diplomacy Remains the Key to Mideast Stability
U.S. diplomacy remains the key to regional stability.

more info



Custom Search

More Politics Articles:

Related Articles

5 Financial Pressure Points To Evaluate During COVID Times


Financial pressure is a part of life for most people, and now the COVID-19 pandemic has brought new financial pressure points or exacerbated existing ones for many individuals and families.

Why Are People Complaining About Innovative COVID Treatments?


Gilead Sciences just announced it will charge $3,120 for a full course of Remdesivir, the first new FDA-approved treatment for COVID-19. Some knee-jerk members of Congress like Lloyd Doggett (D-Tex.) immediately condemned that price tag as "outrageous." The Institute for Clinical and Economic Review, a left-leaning nonprofit that releases its own recommendations of "fair" drug prices, claimed that Gilead could afford to price Remdesivir as low as $10 per course of treatment -- the cost of the raw ingredients used to make the drug.

Proposed Healthcare Reforms Will Not Help the Latinx Community


Joe Biden is officially the Democratic presidential nominee, all thanks to his moderate reputation.

Trade Enforcement Can Accelerate America's Economic Recovery


The stock market has largely rebounded from COVID-19 and American retail sales are improving steadily. Even more encouraging is that the U.S. unemployment rate fell for the fifth consecutive month in September. Each of these gains are sure signs that the Trump administration's economic response to the coronavirus crisis is working.

Drug Price Controls: Right Objective, Wrong Solution


This month, President Trump signed an executive order to reduce Medicare spending on prescription drugs. For each medication, Medicare will pay no more than the lowest price available in other developed countries.

Keep Thanksgiving, Family and Friends Alive


Joe Biden or Donald Trump will never visit me in my home, stand beside me at the funeral home or dance at my wedding. I will not be receiving any calls from either of them to pray for me during sickness or to check on how my children are doing. I probably will never sit in a room with them to visit, laugh and tell funny stories or just to hang out over a cup of coffee. I do not personally know either one. I welcome the opportunity to visit with either of them, but doubt it will happen.

The "E" Stands for “Excellence:” Remembering Walter E. Williams


Walter E. Williams, prolific author, piercing cultural commentator, old school economist (that’s a good thing), devoted husband, loving father, and long-time friend of Grove City College has passed from this world.

How Congress Can Really Fix Surprise Billing


House and Senate leaders recently agreed on legislation to end surprise medical bills as part of a big coronavirus relief package. President Trump signed it into law at the end of December.

A Federal Rule Will Reverse Strides in Cancer Treatment


"You've got cancer." That's one of the scariest sentences in the English language.

Biden Must Restore Seniors' Access to Essential Medicines


On January 19, Medicare officials announced a new payment model that could wreak havoc on the chronically ill.

Violence In America, Don't Be Surprised


The most recent attack at the United States Capitol will most likely insure a permanent fence and additional security. The attack which resulted in the loss of life for a long serving Capitol police officer and the attacker is another senseless violent act.

Protecting the Innovation that Protects Global Health


The most far-reaching healthcare policy decision of 2021 won't be made in Congress or the White House. It will be made at the World Trade Organization, which is considering a petition to waive all patent rights on Covid-19 vaccines.

Don't Repeat Europe's Vaccine Catastrophe


For many Americans, the calamitously slow vaccine roll-out in countries like Germany, France, and Italy comes as a surprise. After all, in the early days of the pandemic, Europe's response to the crisis seemed highly competent, especially compared to the United States.

A Full Plate for the New U.S. Trade Czar


The newly confirmed U.S. trade representative, Katherine Tai, is about as qualified as a person can be for the job. Which is a good thing, because she already faces a series of challenges.

Don't Let the US Import Europe's Failed Cancer Policies


With a majority in both the House and Senate and control of the Oval Office, Democratic leaders are excited about the prospect of making significant changes. One good example of this is the House Democrats' "Lower Drug Costs Now Act."